
Claris Bio
Developer of a topical formulation technology designed to treat orphan ophthalmic disorders. The company's technology creates a recombinant hepatocyte growth factor that accelerates the healing proces...
Valuation
$163.4M
Latest known
Share Price
N/A
Total Raised
$153.6M
Last Round
N/A